Mesenchymal stem cell-mediated cancer therapy: A dual-targeted strategy of personalized medicine.
about
Potential of Mesenchymal Stem Cell based application in CancerPTEN-mRNA engineered mesenchymal stem cell-mediated cytotoxic effects on U251 glioma cellsThe uncertain role of unmodified mesenchymal stem cells in tumor progression: what master switch?Tumor necrosis factor-α/CD40 ligand-engineered mesenchymal stem cells greatly enhanced the antitumor immune response and lifespan in mice.Cancer cell-oriented migration of mesenchymal stem cells engineered with an anticancer gene (PTEN): an imaging demonstration.The application of mRNA-based gene transfer in mesenchymal stem cell-mediated cytotoxicity of glioma cells.Mesenchymal stem cells for systemic therapy: shotgun approach or magic bullets?Targeted inhibition of osteosarcoma tumor growth by bone marrow-derived mesenchymal stem cells expressing cytosine deaminase/5-fluorocytosine in tumor-bearing mice.DCA increases the antitumor effects of capecitabine in a mouse B16 melanoma allograft and a human non-small cell lung cancer A549 xenograft.TRAIL-engineered pancreas-derived mesenchymal stem cells: characterization and cytotoxic effects on pancreatic cancer cells.Role of Mesenchymal Stem Cells in Cancer Development and Their Use in Cancer Therapy.Nucleofection optimization and in vitro anti-tumourigenic effect of TRAIL-expressing human adipose-derived mesenchymal stromal cells.Antitumor activity of yulangsan polysacchrides in mice bearing S180 sarcoma tumors.Isolation, characterization and differentiation of cells expressing pluripotent/multipotent markers from adult human ovaries.[Study on transduction of IL-24 gene in human bone marrow mesenchymal stem cells by lentiviral vector].Intravital biobank and personalized cancer therapy: the correlation with omics.Delivery of Exogenous miR-124 to Glioblastoma Multiform Cells by Wharton's Jelly Mesenchymal Stem Cells Decreases Cell Proliferation and Migration, and Confers Chemosensitivity.Targeting delivery of lipocalin 2-engineered mesenchymal stem cells to colon cancer in order to inhibit liver metastasis in nude mice.
P2860
Q35540034-6BC7A9A4-68E5-44AD-9CF7-3EAE8E85A0E7Q36742113-E302627E-297A-4E61-AC90-9B9C52EBB527Q36998634-E4031103-37C0-493D-925C-91BDB2C91DCFQ37640522-29B72073-880F-49B5-98F3-0D01B88672CDQ37655422-F72B695A-C010-4107-BE33-FB8D1EAC07C0Q37688267-F1E689DC-DB60-44D8-A1EB-D73D23A6CEF2Q38062875-F20079AE-B9FF-46BF-8986-6485DAE4094DQ38895289-EE1825B7-3E40-47D1-A482-5F03819274A8Q39094900-A21C2509-6B83-4D13-AB0C-82EBF5B686EFQ39319003-02780B2B-A84F-489A-9ED4-EE2546E3AF0DQ39449623-AC7CC489-B508-4148-B90C-19259E11414FQ42177775-A6E14452-2370-429D-95C1-6E49C448832BQ42376304-6505399A-1B00-459A-8CC9-7338F5AF5460Q44432734-E798F087-A567-452C-87B3-93CB20AEA549Q46777860-F0FE6440-3E8A-47EA-AA44-70666972436AQ47825939-187D5855-0604-4C38-9C37-3D6EB4187587Q49559607-7D24BA22-D57D-44F8-BBBF-323739BDFA0BQ51001958-547DEC5F-2554-455D-AFD0-82696D4E9651
P2860
Mesenchymal stem cell-mediated cancer therapy: A dual-targeted strategy of personalized medicine.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Mesenchymal stem cell-mediated ...... tegy of personalized medicine.
@en
Mesenchymal stem cell-mediated ...... tegy of personalized medicine.
@nl
type
label
Mesenchymal stem cell-mediated ...... tegy of personalized medicine.
@en
Mesenchymal stem cell-mediated ...... tegy of personalized medicine.
@nl
prefLabel
Mesenchymal stem cell-mediated ...... tegy of personalized medicine.
@en
Mesenchymal stem cell-mediated ...... tegy of personalized medicine.
@nl
P2093
P2860
P356
P1476
Mesenchymal stem cell-mediated ...... tegy of personalized medicine.
@en
P2093
Garth L Warnock
Jiang Nong
Long-Jun Dai
Xu-Yong Sun
P2860
P304
P356
10.4252/WJSC.V3.I11.96
P577
2011-11-01T00:00:00Z